[NRIX] QoQ Quarter Result on 30-Nov-2021 [#Q4]

Stock
[NRIX] Nurix Therapeutics, Inc.
Announcement Date
28-Jan-2022
Financial Year
2021
Quarter
30-Nov-2021 [#Q4]
Profit Trend
QoQ- -30.75%
YoY- -89.32%
Quarter Report
NRIX's Result
NRIX's Financial Summary
View:
Show?
Quarter Result
31/08/22 31/05/22 28/02/22 30/11/21 31/08/21 31/05/21 28/02/21 CAGR
Revenue 10,791 11,432 9,621 7,396 10,252 7,091 5,011 66.52%
PBT -45,709 -45,401 -42,533 -37,658 -28,958 -26,243 -24,204 52.60%
Tax -1,009 -314 -211 44 -123 139 71 -
NP -44,700 -45,087 -42,322 -37,702 -28,835 -26,382 -24,275 50.06%
Tax Rate - - - - - - - -
Total Cost 55,491 56,519 51,943 45,098 39,087 33,473 29,286 52.94%
Ratio Analysis
31/08/22 31/05/22 28/02/22 30/11/21 31/08/21 31/05/21 28/02/21 CAGR
NP Margin -414.23 -394.39 -439.89 -509.76 -281.26 -372.05 -484.43 -9.88%
Per Share
31/08/22 31/05/22 28/02/22 30/11/21 31/08/21 31/05/21 28/02/21 CAGR
EPS -0.88 -1.00 -0.95 -0.85 -0.65 -0.60 -0.63 24.88%
EPS Diluted -0.88 -1.00 -0.95 -0.85 -0.65 -0.60 -0.63 24.88%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.